BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20732354)

  • 21. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
    Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
    Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melanoma differentiation associated gene-7/interleukin-24 potently induces apoptosis in human myeloid leukemia cells through a process regulated by endoplasmic reticulum stress.
    Rahmani M; Mayo M; Dash R; Sokhi UK; Dmitriev IP; Sarkar D; Dent P; Curiel DT; Fisher PB; Grant S
    Mol Pharmacol; 2010 Dec; 78(6):1096-104. PubMed ID: 20858700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of in vitro pancreatic cancer cell growth inhibition by melanoma differentiation-associated gene-7/interleukin-24 and perillyl alcohol.
    Lebedeva IV; Su ZZ; Vozhilla N; Chatman L; Sarkar D; Dent P; Athar M; Fisher PB
    Cancer Res; 2008 Sep; 68(18):7439-47. PubMed ID: 18768668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cells.
    Yacoub A; Hamed HA; Allegood J; Mitchell C; Spiegel S; Lesniak MS; Ogretmen B; Dash R; Sarkar D; Broaddus WC; Grant S; Curiel DT; Fisher PB; Dent P
    Cancer Res; 2010 Feb; 70(3):1120-9. PubMed ID: 20103619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels.
    Park MA; Hamed HA; Mitchell C; Cruickshanks N; Dash R; Allegood J; Dmitriev IP; Tye G; Ogretmen B; Spiegel S; Yacoub A; Grant S; Curiel DT; Fisher PB; Dent P
    Mol Pharmacol; 2011 Mar; 79(3):368-80. PubMed ID: 21119025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism.
    Chada S; Mhashilkar AM; Ramesh R; Mumm JB; Sutton RB; Bocangel D; Zheng M; Grimm EA; Ekmekcioglu S
    Mol Ther; 2004 Dec; 10(6):1085-95. PubMed ID: 15564140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells.
    Dash R; Dmitriev I; Su ZZ; Bhutia SK; Azab B; Vozhilla N; Yacoub A; Dent P; Curiel DT; Sarkar D; Fisher PB
    Cancer Gene Ther; 2010 Jul; 17(7):447-56. PubMed ID: 20150932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study.
    Cunningham CC; Chada S; Merritt JA; Tong A; Senzer N; Zhang Y; Mhashilkar A; Parker K; Vukelja S; Richards D; Hood J; Coffee K; Nemunaitis J
    Mol Ther; 2005 Jan; 11(1):149-59. PubMed ID: 15585416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression analysis and genomic characterization of human melanoma differentiation associated gene-5, mda-5: a novel type I interferon-responsive apoptosis-inducing gene.
    Kang DC; Gopalkrishnan RV; Lin L; Randolph A; Valerie K; Pestka S; Fisher PB
    Oncogene; 2004 Mar; 23(9):1789-800. PubMed ID: 14676839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired and innate resistance to the cancer-specific apoptosis-inducing cytokine, mda-7/IL-24: not insurmountable therapeutic problems.
    Sarkar D; Dent P; Curiel DT; Fisher PB
    Cancer Biol Ther; 2008 Jan; 7(1):109-12. PubMed ID: 18277093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanistic aspects of mda-7/IL-24 cancer cell selectivity analysed via a bacterial fusion protein.
    Sauane M; Gopalkrishnan RV; Choo HT; Gupta P; Lebedeva IV; Yacoub A; Dent P; Fisher PB
    Oncogene; 2004 Oct; 23(46):7679-90. PubMed ID: 15334067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
    Miyahara R; Banerjee S; Kawano K; Efferson C; Tsuda N; Miyahara Y; Ioannides CG; Chada S; Ramesh R
    Cancer Gene Ther; 2006 Aug; 13(8):753-61. PubMed ID: 16543916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanoma differentiation associated gene-7/interleukin-24 promotes tumor cell-specific apoptosis through both secretory and nonsecretory pathways.
    Sauane M; Lebedeva IV; Su ZZ; Choo HT; Randolph A; Valerie K; Dent P; Gopalkrishnan RV; Fisher PB
    Cancer Res; 2004 May; 64(9):2988-93. PubMed ID: 15126330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells.
    Azab B; Dash R; Das SK; Bhutia SK; Shen XN; Quinn BA; Sarkar S; Wang XY; Hedvat M; Dmitriev IP; Curiel DT; Grant S; Dent P; Reed JC; Pellecchia M; Sarkar D; Fisher PB
    J Cell Physiol; 2012 May; 227(5):2145-53. PubMed ID: 21780116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent antitumor effect elicited by RGD-mda-7, an mda-7/IL-24 mutant, via targeting the integrin receptor of tumor cells.
    Zhang BF; Liu JJ; Pei DS; Yang ZX; Di JH; Chen FF; Li HZ; Xu W; Wu YP; Zheng JN
    Cancer Biother Radiopharm; 2011 Oct; 26(5):647-55. PubMed ID: 21902545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma differentiation associated gene-7 (mda-7)/IL-24: a 'magic bullet' for cancer therapy?
    Sarkar D; Lebedeva IV; Gupta P; Emdad L; Sauane M; Dent P; Curiel DT; Fisher PB
    Expert Opin Biol Ther; 2007 May; 7(5):577-86. PubMed ID: 17477796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.
    Ablin RJ; Kynaston HG; Mason MD; Jiang WG
    J Transl Med; 2011 Apr; 9():49. PubMed ID: 21524313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone deacetylase inhibitors interact with melanoma differentiation associated-7/interleukin-24 to kill primary human glioblastoma cells.
    Hamed HA; Yacoub A; Park MA; Archer K; Das SK; Sarkar D; Grant S; Fisher PB; Dent P
    Mol Pharmacol; 2013 Aug; 84(2):171-81. PubMed ID: 23661648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner.
    Su ZZ; Lebedeva IV; Sarkar D; Gopalkrishnan RV; Sauane M; Sigmon C; Yacoub A; Valerie K; Dent P; Fisher PB
    Oncogene; 2003 Feb; 22(8):1164-80. PubMed ID: 12606943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer.
    Oida Y; Gopalan B; Miyahara R; Inoue S; Branch CD; Mhashilkar AM; Lin E; Bekele BN; Roth JA; Chada S; Ramesh R
    Mol Cancer Ther; 2005 Feb; 4(2):291-304. PubMed ID: 15713900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.